Finasteride is an oral treatment for male pattern baldness caused by sensitivity to dihydrotestosterone (DHT). It is intended for adult men and can slow hair loss by reducing DHT activity around…
Finasteride is an oral treatment for male pattern baldness caused by sensitivity to dihydrotestosterone (DHT). It is intended for adult men and can slow hair loss by reducing DHT activity around scalp follicles.
Finasteride is the active substance in these pills. It belongs to the 5-alpha-reductase inhibitor class and is used mainly for male pattern baldness, also called androgenetic alopecia.
Finasteride pills are taken by mouth according to the regimen confirmed for the selected strength. The usual approach for hair loss is regular daily treatment, but the exact strength and schedule must be established before starting.
Practical administration points include:
Hair grows in cycles, so the response cannot be judged after a few days. Reduced shedding may appear before visible thickening. Many users need several months of daily treatment before deciding whether the response is meaningful, and the benefit is maintained only while treatment continues.
A temporary change in shedding can occur during the treatment period. Rapidly increasing loss, patchy bald areas, scalp inflammation, or sudden loss of eyebrows and body hair suggests another diagnosis and requires clinical assessment.
Finasteride is the active substance in these oral pills. It belongs to the 5-alpha-reductase inhibitor class and is used mainly for male pattern baldness, also called androgenetic alopecia. It reduces DHT activity around scalp follicles and is intended for adult men. Different strengths are used for different medical purposes, including hair loss and benign prostatic hyperplasia.
The medicine reduces the conversion of testosterone into dihydrotestosterone, or DHT, a hormone that can gradually shrink susceptible hair follicles.
Hair follicles affected by DHT enter shorter growth cycles. The hairs become finer, remain shorter, and eventually become difficult to see. This process is called follicular miniaturisation. By lowering DHT exposure in the scalp, Finasteride can slow this process and support the maintenance of existing hair.
The biochemical pathway is straightforward:
Finasteride does not create new follicles. It works best when follicles remain active but have begun producing thinner hair. The crown and mid-scalp often respond more clearly than a long-established receding hairline.
Clinical information from the United States Food and Drug Administration describes Finasteride’s role in male pattern hair loss and confirms that results depend on continued treatment [1].
Finasteride is supplied in different strengths for different medical purposes. Lower-strength treatment is associated with male pattern baldness, while higher-strength treatment is used for benign prostatic hyperplasia, a non-cancerous enlargement of the prostate.
Finasteride for hair loss is intended for adult men.
Several routine mistakes make Finasteride harder to assess:
One missed dose is not a reason to double the next dose. Taking extra Finasteride does not accelerate follicle recovery and can increase exposure without improving the result.
Another common error is judging the hairline alone. The temples may respond less than the crown, so assessment should include consistent photographs of several scalp areas.
PDE5 inhibitors must not be combined with nitrate medicines used for chest pain because the combination can cause a dangerous fall in blood pressure.
Finasteride is NOT for you if the cause of hair loss is sudden or unexplained, or if you have a relevant allergy or worsening depression or suicidal thoughts. Women who are pregnant or may become pregnant should not handle crushed or broken Finasteride tablets. Intact tablets have a protective coating, but broken tablets may expose the skin to the active substance.
It should not be used to mask urinary symptoms, blood in the urine, painful urination, or unexplained pelvic pain.
Finasteride is generally tolerated by many users, but it can affect sexual function, mood, and breast tissue. Hair improvement must be balanced against these possible reactions.
Reported sexual adverse effects include:
In clinical trials for male pattern baldness, sexual adverse events were reported more often with Finasteride than with placebo, although the absolute difference was small. The FDA prescribing information also records that some reactions continued after treatment stopped in post-marketing reports, though the frequency and cause cannot always be established from those reports [2].
Mood changes require attention. Depression, anxiety, reduced motivation, and suicidal thoughts have been reported during or after Finasteride treatment. A new or worsening depressed mood should be treated as a clinical warning rather than dismissed as an unavoidable part of treatment. Suicidal thoughts require urgent help through local emergency services or a crisis service.
Breast-related symptoms are uncommon but need assessment. Contact a medical service promptly if you develop a breast lump, breast pain, swelling, or nipple discharge. These symptoms can have several causes, including hormonal effects, and should not be self-diagnosed.
Some people report reduced semen volume without a complete loss of fertility. Finasteride can reduce prostate and seminal fluid contributions, so fertility concerns should be discussed before treatment if conception is planned.
A raised prostate-specific antigen, or PSA, can be reduced by Finasteride used for prostate disease. Doctors interpreting PSA results need to know about current or previous Finasteride exposure. This issue is less central to hair-loss treatment but becomes relevant as men age or undergo prostate assessment.
Finasteride, Minoxidil, and Dutasteride act through different pathways. The choice depends on whether hormonal DHT reduction, local follicle stimulation, or another treatment strategy is most appropriate.
| Treatment category | Main mechanism and route | Practical trade-off |
|---|---|---|
| Finasteride | Oral 5-alpha-reductase inhibition; lowers DHT | Addresses a hormonal driver but may cause sexual or mood-related adverse effects |
| Minoxidil | Topical or oral follicle stimulation, depending on formulation | Avoids direct DHT inhibition; topical use may cause scalp irritation and requires regular application |
| Dutasteride | More extensive 5-alpha-reductase inhibition | May produce stronger DHT suppression but has a longer persistence and may carry greater hormonal effects |
Finasteride acts systemically after oral administration. Minoxidil works through a different pharmacological route and does not reduce DHT. It may be used as a topical solution or foam, while oral forms require separate clinical supervision because systemic effects are possible.
Dutasteride inhibits more forms of 5-alpha-reductase than Finasteride. It is used for prostate disease in many settings and may be considered for hair loss outside standard approved indications, depending on local clinical practice. Its longer elimination time means that adverse effects may not resolve as quickly after stopping.
Some men use Finasteride alongside topical Minoxidil. This combines hormonal DHT reduction with a local treatment pathway, but it also increases the number of daily treatment tasks. Scalp irritation, unwanted facial hair, dizziness, or palpitations from Minoxidil-containing products need separate assessment.
In clinical practice, doctors usually assess the pattern of hair loss before prescribing Finasteride. A slowly receding hairline with thinning at the crown fits androgenetic alopecia more closely than sudden round patches, scarring, or inflammation.
A doctor will usually set expectations early. The first goal is often stabilising hair loss, not producing dramatic regrowth. Improvement is measured over months, and the crown may respond differently from the temples.
The European Medicines Agency has reviewed concerns about psychiatric and sexual adverse effects associated with Finasteride and advises attention to depressed mood and suicidal thoughts [3]. This does not mean every user will develop these symptoms. It means that mood changes should be reported promptly rather than ignored.
No specific diet has been shown to replace DHT reduction in male pattern baldness. Regular exercise, adequate protein intake, sufficient sleep, and avoidance of smoking support general health but do not guarantee regrowth. The American Academy of Dermatology’s 2025 patient guidance links hair assessment with checking for nutritional and medical contributors when shedding is atypical. Severe dieting can worsen shedding through rapid weight loss, iron deficiency, or inadequate protein.
Finasteride can generally be taken with food or without food, provided the prescribed schedule is followed. Taking it with a routine meal may make adherence easier for someone who forgets tablets. The FDA prescribing information available through 2025 does not require a special meal relationship for oral Finasteride. A sudden change in stomach symptoms, rash, or swelling after taking a dose needs medical assessment.
Review the treatment only after allowing enough time for the hair cycle to show a change, rather than judging the result after a few weeks. A clinician may check the diagnosis, adherence, scalp health, medicines, thyroid function, iron status, or other causes of shedding. The British Association of Dermatologists’ 2025 guidance distinguishes androgenetic alopecia from conditions such as alopecia areata and scarring hair loss. Do not increase the dose independently.
Finasteride can be used alongside some treatments, but the full medicine list should be reviewed before combining it with erectile dysfunction medicines, prostate medicines, blood-pressure treatments, or supplements marketed for hormonal or sexual health. The New Zealand Formulary information available in 2025 describes the interaction profile as limited, while still requiring attention to the person’s wider treatment plan. Sildenafil or tadalafil require separate cardiovascular screening, especially when nitrates or alpha-blockers are involved. Supplements should also be disclosed because their ingredients and doses vary.
Finasteride can cause erectile dysfunction, reduced libido, ejaculation problems, or reduced ejaculate volume in some users. The FDA’s 2023 prescribing information records sexual adverse events in hair-loss trials and includes post-marketing reports of persistence after stopping. A symptom that begins after treatment deserves a review of timing, other medicines, cardiovascular health, mood, and relationship factors. Do not conceal the symptom or self-treat it with a PDE5 inhibitor without checking for nitrate use.
Older adults may use Finasteride when a clinician confirms the indication and reviews prostate symptoms, PSA interpretation, sexual health, mood, and other medicines. Age alone does not determine suitability. EMA safety information reviewed through 2025 supports attention to psychiatric and sexual symptoms across adult age groups. New urinary symptoms, blood in the urine, breast changes, or unexplained weight loss need assessment rather than treatment with Finasteride alone.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
Based on 5 reviews
I used Finasteride for about five months before I noticed less hair in the shower. The crown looked denser in photographs, although the front hairline changed very little. I did not notice sexual effects.
Blenheim About five months 6 Nov 2026After roughly eight weeks, I had lower interest in sex and stopped taking it after discussing the timing with my doctor. The symptom improved gradually, but I regretted not recording my baseline before starting.
Invercargill Roughly eight weeks 18 Oct 2026The first three months were difficult to judge because shedding continued. By month six, the loss seemed steadier and I decided to continue. Taking the pill with breakfast helped me remember it.
Masterton Six months 30 Oct 2026I used Finasteride for hair loss and later needed a PSA test. The clinic asked about my medicines, which was useful because I had not realised Finasteride could affect the result.
Nelson 10 Oct 2026I stopped after two months because I expected visible regrowth sooner. There was no clear change in that time, and I later learned that the growth cycle made my expectation unrealistic.
Dunedin Two months 24 Oct 2026
